<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03953846</url>
  </required_header>
  <id_info>
    <org_study_id>01003</org_study_id>
    <nct_id>NCT03953846</nct_id>
  </id_info>
  <brief_title>NUsurface Implant Registry</brief_title>
  <acronym>NIR</acronym>
  <official_title>A Long-term Non-interventional Registry Study to Assess the Effectiveness and Safety of the NUsurface® Meniscus Implant</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Active Implants</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Active Implants</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this active post-market surveillance clinical registry study is to further&#xD;
      characterize the therapeutic effect, the long-term safety and effectiveness of the NUsurface®&#xD;
      meniscus implant in the real-world post-marketing setting&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients eligible for the Registry includes any patient who received or is scheduled to&#xD;
      receive the NUsurface® meniscus implant and meets the Registry inclusion criteria (Evidence&#xD;
      of a personally signed and dated informed consent document). The NUsurface Implant Regitstry&#xD;
      is about data collection only and under routine standard of care by treating physician. Data&#xD;
      collection points are pre-op (i.e. baseline), surgery and multiple times after surgery during&#xD;
      the first 6 months to correspond to clinic standard of care schedules, 6 months, 1 year&#xD;
      post-operatively and then yearly thereafter out to 10 years.Surveys used are KOOS; Knee&#xD;
      injury and Osteoarthritis Outcome Score &amp; WOMET; Western Ontario Meniscal Evaluation Tool.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2019</start_date>
  <completion_date type="Anticipated">June 1, 2033</completion_date>
  <primary_completion_date type="Anticipated">June 1, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>10 Years</target_duration>
  <primary_outcome>
    <measure>KOOS (Knee Osteoarthritis Outcome Score) Pain improvement</measure>
    <time_frame>24 months</time_frame>
    <description>a responder is defined as a patient with an increase of at least 20 points on the KOOS pain assessment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>WOMET (Western Ontario Meniscus Evaluation Tool) score improvement</measure>
    <time_frame>24 months</time_frame>
    <description>a responder is defined as a patient with an increase of at least 12 points on the WOMET assessment</description>
  </primary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Meniscus; Degeneration</condition>
  <condition>Knee Osteoarthritis</condition>
  <condition>Knee Pain Chronic</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The study population eligible for this protocol includes any subject who received or is&#xD;
        scheduled to receive the NUsurface® meniscus implant and meets the Registry inclusion&#xD;
        criteria&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  New or current treatment with the NUsurface® meniscus implant&#xD;
&#xD;
          -  Evidence of a personally signed and dated informed consent document indicating that&#xD;
             the subject (or a legally acceptable representative) has been informed of all&#xD;
             pertinent aspects of the Registry.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There are no protocol exclusion criteria; all subjects who meet the inclusion criteria&#xD;
             are eligible for enrollment.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rita Molenaar</last_name>
    <phone>+31.343.200.140</phone>
    <email>r.molenaar@activeimplants.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Cathy Newbill</last_name>
    <phone>901-762-0352</phone>
    <email>cathy.newbill@activeimplants.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>AZ Monica vzw</name>
      <address>
        <city>Deurne</city>
        <zip>BE-2100</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristien Vuylsteke</last_name>
      <phone>+32 (0)3 320 58 42</phone>
      <email>morefoundation@azmonica.be</email>
    </contact>
    <investigator>
      <last_name>Peter Verdonk, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Sporthopaedicum</name>
      <address>
        <city>Berlin</city>
        <zip>10627</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nina Bauer</last_name>
      <phone>+49 (0)30 92105993</phone>
      <email>bauer@arthroskopie.de</email>
    </contact>
    <investigator>
      <last_name>Sven Scheffler, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Brandenburg</name>
      <address>
        <city>Brandenburg an der Havel</city>
        <zip>14770</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mrs Lehman</last_name>
      <phone>+49 3381-41-1900</phone>
      <email>orthopaedie@klinikum-brandenburg.de</email>
    </contact>
    <investigator>
      <last_name>Roland Becker, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sebastian Kopf, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DIAKO Bremen</name>
      <address>
        <city>Bremen</city>
        <zip>28239</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mrs. Hoffmann</last_name>
      <phone>+49 421 6102 1501</phone>
      <email>orthopaedie@diako-bremen.de</email>
    </contact>
    <investigator>
      <last_name>M. Bohnsack, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>B. Bartels, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Elisabeth Krankenhaus</name>
      <address>
        <city>Damme</city>
        <zip>49401</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rianne Berg</last_name>
      <phone>+49 05491 955232</phone>
      <email>rianne.berg@orthop-damme.de</email>
    </contact>
    <investigator>
      <last_name>Berg Tom, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum der Universität München</name>
      <address>
        <city>München</city>
        <zip>81377</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Monika Baylacher</last_name>
      <phone>0049-(0)89-4400-57670</phone>
      <email>monika.baylacher@med.uni-muenchen.de</email>
    </contact>
    <investigator>
      <last_name>Peter Müller, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Thomas Niethammer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Caritas-Krankenhaus St. Josef</name>
      <address>
        <city>Regensburg</city>
        <zip>93053</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sandra Frestl</last_name>
      <phone>+941 782 3810</phone>
      <email>sferstl@caritasstjosef.de</email>
    </contact>
    <contact_backup>
      <email>sferstl@caritasstjosef.de</email>
    </contact_backup>
    <investigator>
      <last_name>Johannes Zellner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assuta MC</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6971028</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hava Klotz</last_name>
      <phone>00972.03.645282</phone>
      <email>havakl@assuta.co.il</email>
    </contact>
    <investigator>
      <last_name>Gabriel Agar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Assuta Medical Center</name>
      <address>
        <city>Tel Aviv</city>
        <zip>6971028</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hava Klotz</last_name>
      <phone>0097 20 364 5282</phone>
      <email>havakl@assuta.co.il</email>
    </contact>
    <contact_backup>
      <last_name>Eric Kachko</last_name>
      <phone>00972 54 581 0625</phone>
      <email>a.kachko@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Gabriel Agar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Shamir Medical Center</name>
      <address>
        <city>Zerifin</city>
        <zip>70300</zip>
        <country>Israel</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karni Barak</last_name>
      <phone>+00972 8977 9432</phone>
      <email>karnib@shamir.gov.il</email>
    </contact>
    <investigator>
      <last_name>Gabriel Agar, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yiftah Beer, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>Germany</country>
    <country>Israel</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>May 15, 2019</study_first_submitted>
  <study_first_submitted_qc>May 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 17, 2019</study_first_posted>
  <last_update_submitted>July 19, 2021</last_update_submitted>
  <last_update_submitted_qc>July 19, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

